BioScience
Baxter plays a significant part in the biotechnology sector and is a pioneer in developing critical therapies to treat chronic diseases.
Baxter is a leading producer of:
- Plasma-based and recombinant clotting factors for haemophilia
- Biopharmaceuticals used to treat immune deficiencies
- Vaccines for the prevention of infectious diseases
- Biosurgery products used for hemostasis and tissue-sealing in surgery
Baxter’s breadth and depth of expertise in recombinant protein manufacturing, plasma fractionation and proprietary Vero-cell vaccine manufacturing technologies set it apart from other companies in these fields.